Safinamide dual molecular mechanisms: sodium channel and glutamate modulation as a translational rationale for neuropathic pain - A narrative review.

Bhui U, Pal R, Chakraborty A, Sridhar SB, Panigrahy UP, Mantry S, Kumar B

Open source

DOI
10.1515/dmpt-2026-0021
Published
2026 Aug 26
Container
Drug metabolism and personalized therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1515/dmpt-2026-0021,
  title = {Safinamide dual molecular mechanisms: sodium channel and glutamate modulation as a translational rationale for neuropathic pain - A narrative review.},
  author = {Bhui U and Pal R and Chakraborty A and Sridhar SB and Panigrahy UP and Mantry S and Kumar B},
  year = {2026},
  journal = {Drug metabolism and personalized therapy},
  doi = {10.1515/dmpt-2026-0021},
  url = {https://doi.org/10.1515/dmpt-2026-0021}
}

RIS

TY  - JOUR
TI  - Safinamide dual molecular mechanisms: sodium channel and glutamate modulation as a translational rationale for neuropathic pain - A narrative review.
AU  - Bhui U
AU  - Pal R
AU  - Chakraborty A
AU  - Sridhar SB
AU  - Panigrahy UP
AU  - Mantry S
AU  - Kumar B
PY  - 2026
JO  - Drug metabolism and personalized therapy
DO  - 10.1515/dmpt-2026-0021
UR  - https://doi.org/10.1515/dmpt-2026-0021
ER  - 

APA

U, B., R, P., A, C., SB, S., UP, P., S, M., & B, K. (2026). Safinamide dual molecular mechanisms: sodium channel and glutamate modulation as a translational rationale for neuropathic pain - A narrative review.. Drug metabolism and personalized therapy. https://doi.org/10.1515/dmpt-2026-0021

Source records